Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2005
11/30/2005CN1229097C Long-acting hair fixing mousse
11/30/2005CN1229032C Process and production for promoting weight loss for overweight dogs
11/30/2005CA2502142A1 Transdermal therapeutic systems
11/29/2005US6969770 reacting an alpha-keto carboxy acid ester or derivative with a pyrrolidinone to form an intermediate, subjecting the intermediate to asymmetric hydrogenation using a chiral catalyst to form the end product
11/29/2005US6969766 PNA monomer and precursor
11/29/2005US6969765 Photosensitizer and method for production thereof
11/29/2005US6969760 Jak kinases and regulation of cytokine signal transduction
11/29/2005US6969732 Central nervous system diosrders; psychological disorders
11/29/2005US6969731 Protease inhibitors that overcome drug resistance
11/29/2005US6969729 An indole or benz(g)indole-2,3-dione-3-oxime compounds; therapeutic treatment of respiratory disorders, urogenital disorders, cardiovascular disorders, brain and psychological disorders, gastrointestinal disorders
11/29/2005US6969728 Antiinflammatory agents
11/29/2005US6969727 Obesity; osteoporosis
11/29/2005US6969726 can be used as anti-proliferative agents and/or anti-infective agents that can be used without limitation as anti-inflammatory agents
11/29/2005US6969725 Oxazole derivatives
11/29/2005US6969724 Compounds
11/29/2005US6969723 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system
11/29/2005US6969722 Amide substituted imidazopyridines
11/29/2005US6969720 2,6,9-trisubstituted purine derivatives which are inhibitors of cyclin/cdk (cyclin dependent kinases) complexes
11/29/2005US6969719 Such as 3-((3-bromo-4-hydroxyphenyl)methyl)-5-ethyl-7,8-dihydro-2-(tetrahydro-2H -pyran-4-yl)amino)-3H-imidazo(2,1-b) purin-4(5H)-one for treating sexual disorders
11/29/2005US6969718 17-β hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
11/29/2005US6969717 Azaindole kinase inhibitors
11/29/2005US6969716 5-phenyl[1,2,4]triazines as ligands for GABA-A α2/α3 receptors for treating anxiety or depression
11/29/2005US6969715 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
11/29/2005US6969714 Imidazolo-5-YL-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
11/29/2005US6969713 Piperidine and piperazine acetamide derivatives
11/29/2005US6969710 Compounds
11/29/2005US6969709 Macrocycles useful in the treatment of Alzheimer's disease
11/29/2005US6969708 Process for the preparation of a high purity composition comprising (7α, 17α)- 17-hydroxy- 7-methyl- 19-nor-17-pregn-5(10)-en-20-yn-3-one
11/29/2005US6969707 For therapy or inhibiting the development of a pathology associated with peroxynitrite damage
11/29/2005US6969706 Preserved pharmaceutical compositions comprising cyclodextrins
11/29/2005US6969705 Compound for use in the treatment of thrombosis
11/29/2005US6969704 contacting the cells of the tissue ex vivo with a nucleic acid containing the polynucleotide sequence 5'-CTTGGCCGCTGCCAT-3' prior to the tissue's transplantation into a subject, for reducing damage to an ischemic tissue
11/29/2005US6969702 in patient exhibiting disorder selected from neurodegenerative disorders, ischemic disorders, neurological traumas, and learning and memory disorders; calcitonin, exendin and their analogs that elevate intracellular cAMP levels in the tissue
11/29/2005US6969592 Method for predicting the sensitivity to chemotherapy
11/29/2005US6969533 Beverage and additive for inflamed tissue
11/29/2005US6969528 novel phosphorus-containing dendrimers which are functionalized at the level of the inner layers and which comprise protonated tertiary amines as ends, have particularly advantageous properties as vectors for transferring nucleic acids
11/29/2005US6969511 Synthetic bulk laxative
11/29/2005US6969508 Buccal aerosol sprays or capsules using polar and non-polar solvent which provide biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect
11/29/2005US6969383 Method for treating severe tinnitus
11/29/2005CA2500217C Crystal forms of azithromycin
11/29/2005CA2374041C Method for increasing propionate in the gastro-intestinal tract
11/29/2005CA2367013C Metered dose inhaler for fluticasone propionate
11/29/2005CA2355493C Therapeutic compositions comprising excess enantiomer
11/29/2005CA2344108C Novel derivatives of cyclobuta-indole carboxamide, process for preparing them and pharmaceutical compositions containing them
11/29/2005CA2332513C New derivatives of 4-sulfonamide piperidine, preparation process thereof and the pharmaceutical compositions they contain
11/29/2005CA2326660C Method for producing transdermal therapeutic systems by using basic alkali metal salts for converting active agent salts into free bases
11/29/2005CA2308532C Use of bisphosphonates for the treatment of osteogenesis imperfecta
11/29/2005CA2288445C 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
11/29/2005CA2251430C Omeprazole formulation
11/29/2005CA2247616C Morphine and diamorphine salts of anionic non-narcotic analgesics of the substituted carboxylic acid type
11/29/2005CA2244245C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
11/29/2005CA2240462C High-content famciclovir tablets
11/29/2005CA2183764C Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
11/29/2005CA2174628C Novel spin trap nitronyl hindered phenols
11/29/2005CA2164704C Use of cobalamins for topical treatment of dermatological illnesses
11/29/2005CA2123048C Tetrazole derivatives of bile acids, processes for their preparation and the use of these compounds as medicaments
11/29/2005CA2099213C 4-iminoquinolines, processes for their preparation, and their use
11/29/2005CA2081068C Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of .alpha.-d-neuraminic acid
11/29/2005CA2080545C Salts of hydrazones
11/29/2005CA2070799C Thioxanthenone antitumor agents
11/28/2005CA2508096A1 Percutaneous absorption accelerator
11/28/2005CA2508093A1 Preparation for external use on skin
11/24/2005WO2005111605A2 Biomarkers for the prediction and treatment of drug-induced diarrhoea
11/24/2005WO2005111224A2 Water-soluble coenzyme q10 in inclusion complex with beta-cyclodextrin, process of preparing, and use thereof
11/24/2005WO2005111223A1 Topical regulation of triglyceride metabolism
11/24/2005WO2005111213A1 Target gene mimitin of myc
11/24/2005WO2005111208A1 Method of proliferating plasma cell
11/24/2005WO2005111196A1 Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates
11/24/2005WO2005111112A2 Cellulose and acrylic based polymers and the use thereof for the treatment of infectious diseases
11/24/2005WO2005111056A1 New esters of adenosine nucleosides and carboxylic acid
11/24/2005WO2005111055A1 Novel antibiotic kigamicins and use thereof
11/24/2005WO2005111053A2 Pharmaceutical compositions having anti-inflammatory activity
11/24/2005WO2005111044A1 4-substituted-1,5-dihydro-pyrido[3,2-b]indol-2-ones
11/24/2005WO2005111042A1 Novel indole derivatives as selective androgen receptor modulators (sarms)
11/24/2005WO2005111041A1 Compounds containing a n-heteroaryl moiety linked to fused ring moieties for the inhibition of nad(p)h oxidases and platelet activation
11/24/2005WO2005111039A2 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
11/24/2005WO2005111037A1 Beta-carbolines useful for treating inflammatory disease
11/24/2005WO2005111036A1 Tetrahydronaphthyridine derivatives useful as histamine h3 receptor ligands
11/24/2005WO2005111032A1 New amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indl-2-one hydrochloride) and process to produce the same
11/24/2005WO2005111031A2 Neuropeptide receptor modulators
11/24/2005WO2005111030A1 Quinolone antibacterial agents
11/24/2005WO2005111028A1 Novel indole derivatives as selective androgen receptor modulators (sarms)
11/24/2005WO2005111027A1 Novel method of synthesising 1,3,4,5-tetrahydro-2h-3-benzazepin-2-one derivatives and use thereof in the synthesis of ivabradine and the salts thereof for addition to a pharmaceutically acceptable acid
11/24/2005WO2005111024A1 Pyrimidine derivatives for the treatment of abnormal cell growth
11/24/2005WO2005111022A1 Pyrimidines derivatives for the treatment of abnormal cell growth
11/24/2005WO2005111021A1 Preparation of candesartan cilexetil in high purity
11/24/2005WO2005111020A2 Pyrimidine hydantoin analogues which inhibit leukocyte adhesion mediated by vla-4
11/24/2005WO2005111016A1 Pyrimidine derivatives for the treatment of abnormal cell growth
11/24/2005WO2005111015A1 Substituted pyrrolidine derivative
11/24/2005WO2005111007A1 Thiazole compound and use thereof
11/24/2005WO2005111004A1 Novel sustained-action bronchodilating agents for use in the treatment of respiratory diseases
11/24/2005WO2005111003A1 Amino-tetrazoles analogues and methods of use
11/24/2005WO2005111001A1 Novel fused heterocycles and uses thereof
11/24/2005WO2005110999A1 Novel imidazole derivatives, the production thereof, and the use of the same as intermediate products for producing medicaments and pesticides
11/24/2005WO2005110996A1 Novel cis-imidazolines
11/24/2005WO2005110995A1 Cationic dyes and dyestuff for keratin fibres, containing said compounds
11/24/2005WO2005110993A1 Novel method of synthesising ivabradine and the salts thereof for addition to a pharmaceutically acceptable acid
11/24/2005WO2005110992A1 Amido compounds and their use as pharmaceuticals
11/24/2005WO2005110991A1 1-aryl-4-substituted isoquinolines
11/24/2005WO2005110989A1 Substituted 1-heteroaryl-4-substituted piperazine and piperidine analogues
1 ... 4454 4455 4456 4457 4458 4459 4460 4461 4462 4463 4464 4465 4466 4467 4468 4469 4470 4471 4472 4473 4474 ... 7860